PTRF, also named CAVIN1, is an unfavorable prognosis marker for ovarian, urothelial, and colorectal cancers, whereas SDPR (known as CAVIN2) is associated with a favorable prognosis in renal cancer and a poor prognosis in stomach cancer. The gene discussed is CAVIN2; the disease is gastric cancer.